XML 17 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2019
Apr. 01, 2018
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2016
Assets          
Cash and cash equivalents $ 8,729   $ 9,424 $ 17,307 $ 15,542
Accounts receivable, net 14,804 $ 9,020 8,736    
Revenue earned but not billed 3,746        
Inventories, net 13,403   7,826    
Deferred contract costs 0   1,000    
Prepaid expenses and other current assets 695   2,467    
Total current assets 41,377   29,453    
Property and equipment, net 12,010   12,894    
Other intangible assets, net 2,469   2,868    
Other long-term assets 165   110    
Total assets 56,021   45,325    
Liabilities and Shareholders’ Equity          
Accounts payable 19,706   11,675    
Accrued expenses and other 7,410   4,171    
Deferred revenue, current 123   499    
Current maturities of long-term debt 96   79    
Total current liabilities 27,335   16,424    
Revolving credit facility 9,202   3,908    
Long-term debt, less current maturities 81   105    
Deferred revenue, long-term 791   940    
Other long-term liabilities 642   524    
Total liabilities 38,051   21,901    
Commitments and contingencies (Note 13)      
Shareholders’ equity:          
Preferred stock, $0.01 par value: Shares authorized: 30,000,000 shares at March 31, 2019 and 2018; no shares issued and outstanding at March 31, 2019 and 2018   0    
Common stock, no par value: Shares authorized: 200,000,000 at March 31, 2019 and 2018; shares issued: 39,037,969 and 38,384,575 at March 31, 2019 and 2018; shares outstanding: 29,600,158 and 28,953,183 at March 31, 2019 and 2018     0    
Additional paid-in capital 155,828   155,003    
Treasury stock: 9,437,811 and 9,431,392 common shares at March 31, 2019 and 2018 (36,091)   (36,085)    
Retained deficit (101,767)   (95,494)    
Total shareholders’ equity 17,970   23,424 $ 35,450 $ 45,983
Total liabilities and shareholders’ equity $ 56,021   $ 45,325